WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsParasitic infections
Open this folder and view contentsInsect and arachnid bites and stings
Open this folder and view contentsSuperficial fungal infections
Open this folder and view contentsSubcutaneous fungal infections
Open this folder and view contentsBacterial infections
Open this folder and view contentsViral infections
Open this folder and view contentsEczematous diseases
Open this folder and view contentsScaling diseases
Open this folder and view contentsPapulosquamous diseases
View the documentCutaneous reactions to drugs
Open this folder and view contentsPigmentary disorders
Open this folder and view contentsPremalignant lesions and malignant tumours
Open this folder and view contentsPhotodermatoses
Open this folder and view contentsBullous dermatoses
View the documentAlopecia areata
View the documentUrticaria
Open this folder and view contentsConditions common in children
View the documentAcne vulgaris
View the documentPruritus
View the documentTropical ulcers
Open this folder and view contentsAntimicrobial drugs
Open this folder and view contentsAntifugal drugs
Open this folder and view contentsAntiseptic agents
Open this folder and view contentsKeratoplastic and keratolytic agents
Open this folder and view contentsScabicides and pediculicides
Open this folder and view contentsAnti-inflammatory and antipruritic drugs1
Open this folder and view contentsAntiallergics and drugs used in anaphylaxis
Close this folderUltraviolet radiation-blocking agents (sunscreens)
View the documentp-Aminobenzoic acid (PABA)
View the documentBenzophenones, cinnamates, dibenzoylmethanes, salicylates
View the documentTitanium dioxide
View the documentZinc oxide
Open this folder and view contentsMiscellaneous drugs
Open this folder and view contentsAnnex
View the documentSelected WHO Publications of Related Interest
View the documentBack cover
 

p-Aminobenzoic acid (PABA)

SPF 15 or above
Creams, lotions, gels, lip waxes

General information

These products absorb mainly ultraviolet B.

Clinical information

Uses

To prevent sunburn, premature ageing of the skin, and skin cancer and related lesions. It may also provide some protection in photosensitive disorders caused by ultraviolet B.

Dosage and administration

Adults and children: products should be applied generously to all exposed areas at least 30 minutes before exposure to sunlight. Water-resistant products should be used for swimming or wet work. Products should be reapplied every 1-2 hours or after swimming or profuse sweating.

Adverse effects

Contact dermatitis and photosensitivity occur more commonly than with other sunscreen products. p-Aminobenzoic acid is now used less frequently in commercial sunscreens for this reason.

Storage

Preparations should be stored in tightly closed containers, protected from light.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019